glp 1 als The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of GLP-1 and the kidney: from

Description

Glucagon-like peptide-1 (GLP-1) is a natural hormone released in the intestines to regulate blood sugar levels and metabolism

These new supplemental products are offering similar benefits to drugs like Ozempic but experts say it may be a placebo effect.

Obesity management: Used widely for weight loss, even in non-diabetic individuals

There is increasing interest in whether and how GLP-1 medicines impact adipose tissue, muscle, and bone, questions with important clinical implications, especially in individuals who may be frail and experiencing rapid and substantial weight loss

These trends suggest that GLP-1s are reshaping treatment patterns most significantly in markets where few alternatives exist and where their effectiveness is increasingly valued